Revenue (Tables)

12 Months Ended

Sep. 28, 2024

The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:


		Years Ended
		September 28, 2024						September 30, 2023						September 24, 2022
Business (in millions)		United States		Intl.		Total		United States		Intl.		Total		United States		Intl.		Total
Diagnostics:
	Cytology & Perinatal	$	283.3	$	195.9	$	479.2	$	297.4	$	183.2	$	480.6	$	300.4	$	174.3	$	474.7
	Molecular Diagnostics	999.1		273.4		1,272.5		1,061.0		300.7		1,361.7		1,694.5		816.9		2,511.4
	Blood Screening	30.3		—		30.3		37.8		—		37.8		32.4		—		32.4
Total		1,312.7		469.3		1,782.0		1,396.2		483.9		1,880.1		2,027.3		991.2		3,018.5

Breast Health:
	Breast Imaging	932.9		277.8		1,210.7		884.0		260.2		1,144.2		735.1		216.5		951.6
	Interventional Breast Solutions	244.6		67.6		312.2		232.6		55.9		288.5		222.1		54.1		276.2

Total		1,177.5		345.4		1,522.9		1,116.6		316.1		1,432.7		957.2		270.6		1,227.8

GYN Surgical		482.5		158.8		641.3		475.3		128.9		604.2		423.8		99.1		522.9

Skeletal Health		51.4		32.7		84.1		69.9		43.5		113.4		59.6		34.0		93.6


Total		$	3,024.1	$	1,006.2	$	4,030.3	$	3,058.0	$	972.4	$	4,030.4	$	3,467.9	$	1,394.9	$	4,862.8


	Years Ended
Geographic Regions (in millions)		September 28, 2024		September 30, 2023		September 24, 2022
United States		$	3,024.1	$	3,058.0	$	3,467.9
Europe		532.7		520.3		888.5
Asia-Pacific		259.6		255.7		359.7
Rest of World		213.9		196.4		146.7
		$	4,030.3	$	4,030.4	$	4,862.8

The following table provides revenue recognized by source:


	Years Ended
Revenue by type (in millions)		September 28, 2024		September 30, 2023		September 24, 2022
Disposables		$	2,490.2	$	2,539.4	$	3,603.6
Capital equipment, components and software		764.9		740.5		587.6
Service		758.2		730.5		652.4
Other		17.0		20.0		19.2
		$	4,030.3	$	4,030.4	$	4,862.8